Affinity Asset Advisors, LLC Purchases in Q2 2025

Affinity Asset Advisors, LLC

  • $596 Million
  • Q2 2025
Stock Shares change Price Range Shares Held Trade History
INSM
Insmed Inc

Healthcare
335K
+ 239.29%
$64.81 - $105.9 $21.7M - $35.5M
475K $47.8M
BPMC
Blueprint Medicines Corp

Healthcare
250K
New
$79.22 - $128.4 $19.8M - $32.1M
250K $32M
VTYX
Ventyx Biosciences, Inc.

Healthcare
4.54M
New
$0.84 - $2.65 $3.81M - $12M
4.54M $9.71M
TRVI
Trevi Therapeutics, Inc.

Healthcare
1.28M
+ 102.72%
$5.28 - $7.06 $6.78M - $9.07M
2.53M $13.9M
PTGX
Protagonist Therapeutics, Inc

Healthcare
40K
+ 10.0%
$40.89 - $56.37 $1.64M - $2.25M
440K $24.3M
RZLT
Rezolute, Inc.

Healthcare
500K
+ 29.41%
$2.47 - $4.46 $1.24M - $2.23M
2.2M $9.81M
VERA
Vera Therapeutics, Inc.

Healthcare
190K
+ 53.46%
$18.86 - $32.0 $3.58M - $6.08M
545K $12.8M
AKBA
Akebia Therapeutics, Inc.

Healthcare
450K
+ 30.0%
$1.55 - $3.97 $698K - $1.79M
1.95M $7.1M
PCVX
Vaxcyte, Inc.

Healthcare
100K
+ 400.0%
$28.04 - $37.2 $2.8M - $3.72M
125K $4.06M
ROIV
Roivant Sciences Ltd.

Healthcare
250K
+ 166.67%
$9.08 - $11.62 $2.27M - $2.91M
400K $4.51M
PRQR
Pro Qr Therapeutics N.V.

Healthcare
215K
+ 6.55%
$1.12 - $2.16 $241K - $464K
3.5M $7.14M
JAZZ
Jazz Pharmaceuticals PLC

Healthcare
25K
New
$97.78 - $126.44 $2.44M - $3.16M
25K $2.65M
ATXS
Astria Therapeutics, Inc.

Healthcare
300K
New
$3.75 - $5.99 $1.13M - $1.8M
300K $1.61M
NRIX
Nurix Therapeutics, Inc.

Healthcare
157K
+ 19.36%
$8.81 - $12.79 $1.38M - $2.01M
968K $11M
SVRA
Savara Inc

Healthcare
500K
New
$1.99 - $3.4 $995K - $1.7M
500K $1.14M
ERAS
Erasca, Inc.

Healthcare
744K
+ 22.27%
$1.06 - $1.63 $789K - $1.21M
4.09M $5.19M
TSHA
Taysha Gene Therapies, Inc.

Healthcare
200K
New
$1.13 - $2.9 $226K - $580K
200K $462K
Anteris Technologies Global
35K
+ 8.97%
N/A
425K $0
Crescent Biopharma Inc.
280K
New
N/A
280K $0
Engene Holdings Inc
77K
New
N/A
77K $0
Enliven Therapeutics Inc
400K
New
N/A
400K $0
Spyre Therapeutics Inc
125K
+ 25.95%
N/A
607K $0
NAMSW
Newamsterdam Pharma CO Nv Wt E
3.04K
+ 1.26%
N/A
245K $0
Jade Biosciences Inc
65.3K
New
N/A
65.3K $0
Rapport Therapeutics Inc
200K
New
N/A
200K $0
Lexeo Therapeutics Inc
2.11M
+ 142.38%
N/A
3.59M $0
Monopar Therapeutics Inc
5.5K
+ 8.87%
N/A
67.5K $0
Oruka Therapeutics Inc
58.1K
+ 10.66%
N/A
603K $0
Omeros Corp
9.03M
New
N/A
9.03M $0
WVE
Wave Life Sciences Ltd.

Healthcare
175K
+ 9.61%
$5.48 - $8.1 $961K - $1.42M
2M $13M
Activity Summary
Buys All Purchases 31 New Holdings 12 Increased Positions 19 Sells All Sells 23 Reductions 23 Sold out 0 Options Calls 8 Puts 6
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email